Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  DietObesityWomen's HealthIssue 663

Reducing Risk of Diabetes in Pregnancy with a Supplement

A nutritional supplement may help protect women at risk for gestational diabetes....

Advertisement

Previous studies have shown that inositol supplements may help restore fertility in polycystic ovary syndrome, but this is the first evidence that the supplement called myo-inositol may reduce the number of cases of gestational diabetes.

Women who are overweight or obese or have a family history of diabetes are at risk for gestational diabetes, which affects up to 10 percent of pregnancies in the U.S., according to the Centers for Disease Control and Prevention.

Mothers with the condition have trouble dealing with carbohydrates leading to high blood sugar.

Lead author, Dr. Rosario D'Anna, of the Department of Obstetrics at University Hospital in Messina, Italy, added that, "Undiagnosed and untreated gestational diabetes can cause large-for-gestational-stage babies, which may lead to delivery complications."

The researchers selected 220 pregnant women with a family history of type 2 diabetes. Half the women were given two grams of myo-inositol supplements twice a day along with the recommended amount of folic acid, a supplement recommended for all pregnant women. The other women were given only folic acid, from the end of the first trimester throughout pregnancy.

A bottle of 60 650-milligram myo-inositol supplements, available in the U.S. without a prescription, costs about $10. The compound is also found in fruits, nuts, grains, and meats, but not at very high levels.

Of the women who took myo-inositol, six percent developed gestational diabetes, compared to 15 percent of the women who only took folic acid, according to the study

None of the babies in the myo-inositol group met criteria for being overweight, but seven babies in the non-supplement group did, weighing more than eight pounds, 13 ounces.

Dr. Donald Coustan of the Division of Maternal-Fetal Medicine at Women and Infants Hospital of Rhode Island in Providence, who was not part of the study, added that, despite these positive findings, researchers don't know how the supplement works or if it is safe. "The results are promising, but we would need a larger trial and a broader group of women before recommending this supplement."

Diabetes Care, March 21, 2013 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 08 February, 2013 and appeared in  DietObesityWomen's HealthIssue 663

Past five issues: Diabetes Clinical Mastery Series Issue 225 | Issue 765 | Diabetes Clinical Mastery Series Issue 224 | Issue 764 | Diabetes Clinical Mastery Series Issue 223 |

2014 Most Popular Articles:

ADA Issues New Standards of Medical Care for Diabetes
Posted January 02, 2015
Significant Weight Loss and Drop in A1c with New Combo of Lorcaserin and Phentermine
Posted January 16, 2015
Why a Low-Carb Diet Should Be the First Approach in Diabetes Treatment
Posted December 18, 2014
New Guidelines Recommend Off-Loading to Increase Likelihood of Diabetic Foot Ulcer Healing
Posted December 26, 2014
Advancement in the Artificial Pancreas
Posted December 26, 2014
FDA Approves Weight-management Drug Saxenda
Posted December 26, 2014
Type 2 Diabetes Risk Lower for Blood Type O
Posted December 26, 2014
Early Insulin Therapy Makes an Impact
Posted December 26, 2014
Increased Mortality with Combining Sulfonylurea and Insulin
Posted December 26, 2014
Another SGLT2 Shows Positive Results
Posted December 26, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Are you comfortable recommending one of the 4 new FDA-approved weight loss drugs?
CME/CE of the Week
Guy Pupp, DPM, FACFAS

Category: Diabetic Foot
Credits:
 1.0
Search Articles On Diabetes In Control